The postoperative surveillance of patients with colon cancer and rectal cancer

American Journal of Surgery

Volumn 192, Issue 1, 2006, Pages 100-108

  Abir, Farshad ^a   Alva, Suraj ^a   Longo, Walter E ^a   Audiso, Riccardo ^b   Virgo, Katherine S ^c   Johnson, Frank E ^c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WHISTON HOSPITAL   (United Kingdom)

^c SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CEA assays; Colorectal cancer; Follow up programs; PET scan; Postoperative surveillance

Indexed keywords

CARCINOEMBRYONIC ANTIGEN;

ANAMNESIS; BLOOD CELL COUNT; CANCER DIAGNOSIS; CANCER PATIENT; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; COLON CANCER; COLONOSCOPY; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; EVIDENCE BASED MEDICINE; FOLLOW UP; HEALTH PROGRAM; HEALTH SURVEY; HUMAN; LABORATORY TEST; LIVER FUNCTION TEST; LIVER METASTASIS; MEDICAL LITERATURE; PATIENT MONITORING; PHYSICAL EXAMINATION; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECTUM CANCER; REVIEW; STATISTICAL SIGNIFICANCE; SURGICAL PATIENT; SURVIVAL RATE; SURVIVAL TIME; THORAX RADIOGRAPHY;

COLONIC NEOPLASMS; FOLLOW-UP STUDIES; HUMANS; POPULATION SURVEILLANCE; POSTOPERATIVE CARE; RECTAL NEOPLASMS; SURVIVAL RATE;

EID: 33744909352     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2006.01.053     Document Type: Review

References (74)

1. Jemal A., Tiwari R.C., Murray T., et al. Cancer statistics, 2004. CA Cancer J Clin 54 (2004) 8-29
2. Jessup J.M., Menck H.R., Fremgen A., et al. Diagnosing colorectal carcinoma. clinical and molecular approaches. CA Cancer J Clin 47 (1997) 70-92
3. Guillem J.G., Paty P.B., and Cohen A.M. Surgical treatment of colorectal cancer. CA Cancer J Clin 47 (1997) 113-128
4. Chapuis P.H., Dent O.F., Fisher R., et al. A multivariate analysis of clinical and pathological variables in prognosis after resection of large bowel cancer. Br J Surg 72 (1985) 698-702
5. Hughes K.S., Simon R., Songhorabodi S., et al. Resection of the liver for colorectal carcinoma metastases. a multi-institutional study of patterns of recurrence. Surgery 100 (1986) 278-284
6. Ballantyne G.H., and Quin J. Surgical treatment of liver metastases in patients with colorectal cancer. Cancer 71 Suppl (1993) 4252-4266
7. Fong Y., Cohen A.M., Fortner J.G., et al. Liver resection for colorectal metastases. J Clin Oncol 15 (1997) 938-946
8. McAfee M.K., Allen M.S., Trastek V.F., et al. Colorectal lung metastases. results of surgical excision. Ann Thorac Surg 53 (1992) 780-786
9. Macintosh E.L., Rodriguez-Bigas M.A., and Petrelli N.J. In: Johnson F.L., and Virgo K.S. (Eds). Colorectal carcinoma (1997), Mosby, St. Louis 118-131
10. Mariotto A., Warren J.L., Knopf K.B., et al. The prevalence of patients with colorectal carcinoma under care in the U.S. Cancer 98 (2003) 1253-1261
11. Virgo K.S., Vernava A.M., Longo W.E., et al. Cost of patient follow-up after potentially curative colorectal cancer treatment. JAMA 273 (1995) 1837-1841
12. Schoemaker D., Black R., Giles L., et al. Yearly colonoscopy, liver CT, and chest radiography do not influence 5-year survival of colorectal cancer patients. Gastroenterology 114 (1998) 7-14
13. Makela J.T., Laitinen S.O., and Kairaluoma M.I. Five-year follow-up after radical surgery for colorectal cancer. Results of a prospective randomized trial. Arch Surg 130 (1995) 1062-1067
14. Ovaska J., Jarvinen H., Kujari H., et al. Follow-up of patients operated on for colorectal carcinoma. Am J Surg 159 (1990) 593-596
15. Tornqvist A., Ekelund G., and Leandoer L. The value of intensive follow-up after curative resection for colorectal carcinoma. Br J Surg 69 (1982) 725-728
16. Ohlsson B., Breland U., Ekberg H., et al. Follow-up after curative surgery for colorectal carcinoma. Randomized comparison with no follow-up. Dis Colon Rectum 38 (1995) 619-626
17. Deveney K.E., and Way L.W. Follow-up of patients with colorectal cancer. Am J Surg 148 (1984) 717-722
18. Sugarbaker P.H., Gianola F.J., Dwyer A., et al. A simplified plan for follow-up of patients with colon and rectal cancer supported by prospective studies of laboratory and radiologic test results. Surgery 102 (1987) 79-87
19. Bruinvels D.J., Stiggelbout A.M., Kievit J., et al. Follow-up of patients with colorectal cancer. A meta-analysis. Ann Surg 219 (1994) 174-182
20. Cochrane J.P., Williams J.T., Faber R.G., et al. Value of outpatient follow-up after curative surgery for carcinoma of the large bowel. BMJ 280 (1980) 593-595
21. Graham R.A., Wang S., Catalano P.J., et al. Postsurgical surveillance of colon cancer. preliminary cost analysis of physician examination, carcinoembryonic antigen testing, chest x-ray, and colonoscopy. Ann Surg 228 (1998) 59-63
22. Beart Jr. R.W., and O'Connell M.J. Postoperative follow-up of patients with carcinoma of the colon. Mayo Clin Proc 58 (1983) 361-363
23. Kjeldsen B.J., Kronborg O., Fenger C., et al. The pattern of recurrent colorectal cancer in a prospective randomised study and the characteristics of diagnostic tests. Int J Colorectal Dis 12 (1997) 329-334
24. Virgo K.S., Wade T.P., Longo W.E., et al. Surveillance after curative colon cancer resection. practice patterns of surgical subspecialists. Ann Surg Oncol 2 (1995) 472-482
25. Benson III A.B., Desch C.E., Flynn P.J., et al. 2000 update of American Society of Clinical Oncology colorectal cancer surveillance guidelines. J Clin Oncol 18 (2000) 3586-3588
26. Cutait R., Alves V.A., Lopes L.C., et al. Restaging of colorectal cancer based on the identification of lymph node micrometastases through immunoperoxidase staining of CEA and cytokeratins. Dis Colon Rectum 34 (1991) 917-920
27. Gold P., and Freedman S.O. Demonstration of tumor-specific antigens in human colonic carcinomata by immunological tolerance and absorption techniques. J Exp Med 121 (1965) 439-462
28. Hine K.R., Booth S.N., Leonard J.C., et al. Carcinoembryonic antigen concentrations in undiagnosed patients. Lancet 2 (1978) 1337-1340
29. Longo W.E., and Johnson F.E. The preoperative assessment and postoperative surveillance of patients with colon and rectal cancer. Surg Clin North Am 82 (2002) 1091-1108
30. Carl J., Bentzen S.M., Norgaard-Pedersen B., et al. Modelling of serial carcinoembryonic antigen changes in colorectal cancer. Scand J Clin Lab Invest 53 (1993) 751-755
31. Bohm B., Schwenk W., Hucke H.P., et al. Does methodic long-term follow-up affect survival after curative resection of colorectal carcinoma?. Dis Colon Rectum 36 (1993) 280-286
32. Engaras B. Individual cutoff levels of carcinoembryonic antigen and CA 242 indicate recurrence of colorectal cancer with high sensitivity. Dis Colon Rectum 46 (2003) 313-321
33. McCall J.L., Black R.B., Rich C.A., et al. The value of serum carcinoembryonic antigen in predicting recurrent disease following curative resection of colorectal cancer. Dis Colon Rectum 37 (1994) 875-881
34. Moertel C.G., Fleming T.R., Macdonald J.S., et al. An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer. JAMA 270 (1993) 943-947
35. Armitage N.C., Davidson A., Tsikos D., et al. A study of the reliability of carcinoembryonic antigen blood levels in following the course of colorectal cancer. Clin Oncol 10 (1984) 141-147
36. Goldenberg D.M., and Larson S.M. Radioimmunodetection in cancer identification. J Nucl Med 33 (1992) 803-814
37. Bleeker W.A., Mulder N.H., Hermans J., et al. Value and cost of follow-up after adjuvant treatment of patients with Dukes' C colonic cancer. Br J Surg 88 (2001) 101-106
38. Castells A., Bessa X., Daniels M., et al. Value of postoperative surveillance after radical surgery for colorectal cancer. results of a cohort study. Dis Colon Rectum 41 (1998) 714-724
39. Pietra N., Sarli L., Costi R., et al. Role of follow-up in management of local recurrences of colorectal cancer. a prospective, randomized study. Dis Colon Rectum 41 (1998) 1127-1133
40. Fletcher R.H. Carcinoembryonic antigen. Ann Intern Med 104 (1986) 66-73
41. Desch C.E., Benson III A.B., Smith T.J., et al. Recommended colorectal cancer surveillance guidelines by the American Society of Clinical Oncology. J Clin Oncol 17 (1999) 1312
42. Goldstein M.J., and Mitchell E.P. Carcinoembryonic antigen in the staging and follow-up of patients with colorectal cancer. Cancer Invest 23 (2005) 338-351
43. Rocklin M.S., Slomski C.A., and Watne A.L. Postoperative surveillance of patients with carcinoma of the colon and rectum. Am Surg 56 (1990) 22-27
44. Baden H., Andersen B., Augustenborg G., et al. Diagnostic value of gamma-glutamyl transpeptidase and alkaline phosphatase in liver metastases. Surg Gynecol Obstet 133 (1971) 769-773
45. Graffner H., Hultberg B., Johansson B., et al. Detection of recurrent cancer of the colon and rectum. J Surg Oncol 28 (1985) 156-159
46. Safi F., and Beyer H.G. The value of follow-up after curative surgery of colorectal carcinoma. Cancer Detect Prev 17 (1993) 417-424
47. Obrand D.I., and Gordon P.H. Incidence and patterns of recurrence following curative resection for colorectal carcinoma. Dis Colon Rectum 40 (1997) 15-24
48. Abulafi A.M., and Williams N.S. Local recurrence of colorectal cancer. the problem, mechanisms, management and adjuvant therapy. Br J Surg 81 (1994) 7-19
49. Romano G., Esercizio L., Santangelo M., et al. Impact of computed tomography vs. intrarectal ultrasound on the diagnosis, resectability, and prognosis of locally recurrent rectal cancer. Dis Colon Rectum 36 (1993) 261-265
50. Beynon J., Mortensen N.J., Foy D.M., et al. The detection and evaluation of locally recurrent rectal cancer with rectal endosonography. Dis Colon Rectum 32 (1989) 509-517
51. Mascagni D., Corbellini L., Urciuoli P., et al. Endoluminal ultrasound for early detection of local recurrence of rectal cancer. Br J Surg 76 (1989) 1176-1180
52. Scialpi M., Andreatta R., Agugiaro S., et al. Rectal carcinoma. preoperative staging and detection of postoperative local recurrence with transrectal and transvaginal ultrasound. Abdom Imaging 18 (1993) 381-389
53. Milsom J.W., Lavery I.C., Stolfi V.M., et al. The expanding utility of endoluminal ultrasonography in the management of rectal cancer. Surgery 112 (1992) 832-841
54. Romano G., de Rosa P., Vallone G., et al. Intrarectal ultrasound and computed tomography in the pre- and postoperative assessment of patients with rectal cancer. Br J Surg 72 Suppl (1985) S117-S119
55. Rotondano G., Esposito P., Pellecchia L., et al. Early detection of locally recurrent rectal cancer by endosonography. Br J Radiol 70 (1997) 567-571
56. Harewood G.C., Wiersema M.J., Nelson H., et al. A prospective, blinded assessment of the impact of preoperative staging on the management of rectal cancer. Gastroenterology 123 (2002) 24-32
57. Lohnert M.S., Doniec J.M., and Henne-Bruns D. Effectiveness of endoluminal sonography in the identification of occult local rectal cancer recurrences. Dis Colon Rectum 43 (2000) 483-491
58. Morken J.J., Baxter N.N., Madoff R.D., et al. Endorectal ultrasound-directed biopsy. a useful technique to detect local recurrence of rectal cancer. Int J Colorectal Dis 21 (2006) 258-264
59. Moss A.A., Thoeni R.F., Schnyder P., et al. Value of computed tomography in the detection and staging of recurrent rectal carcinomas. J Comput Assist Tomogr 5 (1981) 870-874
60. Flanagan F.L., Dehdashti F., Ogunbiyi O.A., et al. Utility of FDG-PET for investigating unexplained plasma CEA elevation in patients with colorectal cancer. Ann Surg 227 (1998) 319-323
61. Flamen P., Hoekstra O.S., Homans F., et al. Unexplained rising carcinoembryonic antigen (CEA) in the postoperative surveillance of colorectal cancer. the utility of positron emission tomography (PET). Eur J Cancer 37 (2001) 862-869
62. Libutti S.K., Alexander Jr. H.R., Choyke P., et al. A prospective study of 2-[18F] fluoro-2-deoxy-D-glucose/positron emission tomography scan, 99mTc-labeled arcitumomab (CEA-scan), and blind second-look laparotomy for detecting colon cancer recurrence in patients with increasing carcinoembryonic antigen levels. Ann Surg Oncol 8 (2001) 779-786
63. Huebner R.H., Park K.C., Shepherd J.E., et al. A meta-analysis of the literature for whole-body FDG PET detection of recurrent colorectal cancer. J Nucl Med 41 (2000) 1177-1189
64. Kamel I.R., Cohade C., Neyman E., et al. Incremental value of CT in PET/CT of patients with colorectal carcinoma. Abdom Imaging 29 (2004) 663-668
65. Holting T., Schlag P., Steinbacher M., et al. The value of immunoscintigraphy for the operative retreatment of colorectal cancer. Limitations of a new diagnostic method. Cancer 64 (1989) 830-833
66. Abdel-Nabi H., and Doerr R.J. Clinical applications of indium-111-labeled monoclonal antibody imaging in colorectal cancer patients. Semin Nucl Med 23 (1993) 99-113
67. Rutgers E.J. Radio-immunotargeting in colorectal carcinoma. Eur J Cancer 31A (1995) 1243-1247
68. Agnese D.M., Abdessalam S.F., Burak Jr. W.E., et al. Pilot study using a humanized CC49 monoclonal antibody (HuCC49DeltaCH2) to localize recurrent colorectal carcinoma. Ann Surg Oncol 11 (2004) 197-202
69. Kim J.C., Roh S.A., Koo K.H., et al. Preclinical application of radioimmunoguided surgery using anti-carcinoembryonic antigen biparatopic antibody in the colon cancer. Eur Surg Res 37 (2005) 36-44
70. Rodriguez-Bigas M.A., Stulc J.P., Davidson B., et al. Prognostic significance of anastomotic recurrence from colorectal adenocarcinoma. Dis Colon Rectum 35 (1992) 838-842
71. Figueredo A., Rumble R.B., Maroun J., et al. Follow-up of patients with curatively resected colorectal cancer. a practice guideline. BMC Cancer 3 (2003) 26
72. Secco G.B., Fardelli R., Gianquinto D., et al. Efficacy and cost of risk-adapted follow-up in patients after colorectal cancer surgery. a prospective, randomized and controlled trial. Eur J Surg Oncol 28 (2002) 418-423
73. Chassin M.R., Galvin R.W., and Institute of Medicine National Roundtable on Health Care Quality. The urgent need to improve health care quality. JAMA 280 (1998) 1000-1005
74. Johnson F.E., Virgo K.S., Longo W.E., et al. Colorectal cancer patient follow-up after curative-intent surgery. Proc Am Soc Clin Oncol 22 (2003) 297